Redeye believes Sdiptech's Q3 report was weaker than expected, with continued positive organic sales...
Redeye sees a stable Q3 from Formpipe, with sales and adjusted EBIT roughly matching our expectation...
Redeye comments on Doro´s third quarter of the year.
Svedbergs Group posted a soft set of Q3 2024 numbers, with sales coming in 4% below our estimates (n...
Redeye makes negligible changes to its forecasts and valuation following Stille's Q3 report.
Redeye comments on ENEA's Q4 2024 report, which, on a like-for-like basis, aligned with estimates.
Polygiene Group delivered better than expected Q3 report on all key metrics.
Redeye sees a Q3 report matching our expectations on both sales and EBITA.
Redeye comments on Alligator's Q3 report. The main event since our last update was the ALG.
Redeye updates its estimates and valuation following ADDvise releasing its Q3 2024 report, which bro...
Redeye provides an update following Iconovo’s Q3 report.
Redeye’s view on the Q3 report. The organic growth was decent, with a gross margin that progressed.
Q3 EBIT -27% vs cons but orders +31% vs cons Positive Q4 guidance and longer-term outlook reiterated...
Redeye comments on Invisio’s Q3-results which were largely in line with our expectations while the o...
Underliggande portföljbolagen utvecklas väl under kvartalet drivet av fortsatt lönsam tillväxt.
